Introduction {#Sec1}
============

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by qualitative impairments in social interaction and communication skills, accompanied by repetitive and stereotyped behaviors and interests (APA [@CR4]). Family and twin studies have shown that the risk for autism is largely determined by genetic factors (\>90%) (Geschwind and Levitt [@CR12]). However, the pattern of inheritance is not straightforward and may include additive effects of common risk alleles, rare gene mutations (e.g., fragile-X) chromosomal abnormalities (e.g., copy number variants or CNVs), and possibly environmental insults (Mendelsohn and Schaefer [@CR23]). Despite the significant heritability, finding the cause has been daunting due to genetic complexity and phenotypic variation (Szatmari et al. [@CR40]; Abrahams and Geschwind [@CR2]). Such heterogeneity in autism has led researchers to seek for reliable diagnostic tools to create genetically homogenous subgroups.

The study of head circumference and other morphological characteristics has begun to merge into autism research to stratify ASDs into more homogenous subgroups. Excessive head growth found in the first year of life, in children later diagnosed with autism, has been one of the most promising quantitative traits (Miles et al. [@CR27]; Sacco et al. [@CR35]). With respect to other morphological characteristics, an excess of minor physical anomalies (MPAs) in autistic individuals received specific attention (Ozgen et al. [@CR32]). Although in the psychiatric literature the term "MPAs" is generally accepted, morphological features encompass major abnormalities as well as minor variants (Aase [@CR1]; Merks et al. [@CR25]). Minor variants are defined as slight morphological deviations that have no serious medical or cosmetic significance, however, they are of great value to the clinician because (1) they can be utilized as indicators of underlying disease susceptibility or markers of disturbed development (e.g., they are found to be more common in individuals with an obvious major embryonic defect; Aase [@CR1]; McGrath et al. [@CR21]); (2) They serve as external indicators of neurodevelopment because of the close relationship between cerebral and craniofacial development (Hammond et al. [@CR15]); (3) Topography of morphological features could provide clues to the process of ASDs as they reflect adverse events during critical periods of development, usually within the first and second trimester (Lane et al. [@CR19]). Minor variants that are observed in 4% or less of the normal population are termed minor anomalies, and those occurring in more than 4% of the normal population are termed common variants.

There is now robust evidence for the association between morphological abnormalities and autism (Ozgen et al. [@CR32]). Existing studies, however, are limited by a number of methodological constrains: a. lack of standardization of the nomenclature and the absence of uniform diagnostic criteria; b. patients with different ethnic backgrounds were included; c. patients were not physically examined by the investigators specifically for the study; d. lack of control data or use of biased populations (e.g., hospital-based cohorts); e. relatively small sample sizes; f. no reports on interrater reliability; g. lack of consideration on gender effect. Moreover, the majority of studies that have assessed the incidence of morphological abnormalities in autism used the Waldrop scale (vide infra), with occasional modifications and omissions of items (Waldrop et al. [@CR43]; Ismail et al. [@CR18]). While the Waldrop scale is able to distinguish patients from controls, it has been criticized for inherent limitations regarding content and form; i.e., its restricted range of 18 items and low sensitivity (Lane et al. [@CR19]).

With these caveats in mind, here we present an approach to study morphological features in a large sample of children with autism and a matched-case control group by using detailed definitions of the phenotype and an internationally accepted classifying list of 683 morphological features (Merks et al. [@CR26]).

Method {#Sec2}
======

Participants {#Sec3}
------------

We examined all consecutive patients attending the Department of Child and Adolescent Psychiatry (CAP) of the University Medical Center in Utrecht, the Netherlands. This hospital provides health services to a wide range of patients from mainly the centre and south of the Netherlands. During the study period, patients and/or their caregivers were invited in writing to participate both to psychological assessments as to a physical examination. The participants in the ASD group were included only if they had a documented diagnosis of an autistic spectrum disorder (autistic disorder, Asperger's disorder or PDD-NOS). Consensus diagnoses were made for each case, consisting of a developmental history, medical examination, and a structured DSM-IV psychiatric interview by experienced child psychiatrists and confirmed by using ADI-R (Lord et al. [@CR20]). Children with any known syndrome or with mental retardation (ICD-9 codes 317--319; IQ \< 70; Smith and Bostian [@CR38]; Rodier et al. [@CR34]) were excluded. Ethnicity was registered because it can influence the external phenotype (McGrath et al. [@CR21]; Merks et al. [@CR25]). 1,007 controls were examined and analyzed in an identical way. Controls were recruited from the city of Haarlem and the surrounding semirural and rural area, because the region was found to be an excellent representative of the general health profile in the Netherlands (Cluitmans et al. [@CR8]; Van Lier [@CR42]; Merks et al. [@CR24]).

The study procedures were approved at the medical ethics committee (METC) of the University Medical Center, Utrecht, the Netherlands. Patients and controls entered the study only after written informed consent was obtained from themselves and/or their parents.

Terminology and Classification of Morphological Characteristics {#Sec4}
---------------------------------------------------------------

A hierarchical tree was built, comprising 29 major anatomical areas, subdivided into 98 different structures, and containing 683 standardized morphological abnormalities. The morphological abnormalities were classified according to their (presumed) pathogenesis, and subdivided into (a) *Major abnormalities*, caused by abnormal development; and (b) *Minor variants*. The *minor variants* can be subdivided into two categories, based on their prevalence in the normal population: *Minor anomalies*, having a prevalence in the normal population by definition of ≤4%; and *Common variants*, having by definition a prevalence in the normal population of \>4% (Supp. Fig. 1; Aase [@CR1]; Merks et al. [@CR26]).

Morphological Examination (Qualitative and Quantitative measures) {#Sec5}
-----------------------------------------------------------------

All patients and controls were carefully examined in an identical way by the same trained examiner (HMO). The clinical examination consisted of standard morphological measurements and comprised a broad range of qualitative and quantitative physical measurements. All items in the Waldrop-scale were included in this list and a clear differentiation between major abnormalities, minor anomalies and common variants were introduced. It should be emphasized that the distinction between major and minor anomalies is pragmatic, and only defined by the effect on the child. Techniques and standards of measurement were adapted from the studies by Aase ([@CR1]) and Hall and Hall ([@CR14]). Height, weight, head circumference, inner and outer canthal distance, ear length, hand length and palm length were measured and shoe size was converted into foot length. The location of some of these quantitative measurements is displayed in Supp. Fig. 2. No specific equipment other than a ruler and measuring tape was used. Auscultation of the heart, abdominal palpation, examination of internal organs and of the external genitalia was not performed. Body mass index (BMI) is formulated as weight (kg)/height (m)^2^ and interpreted with the reference of Van Buuren ([@CR41]). Palpebral fissure length (PFL) is defined as the distance between the inner and outer canthus of one eye (Hall and Hall [@CR14]).

Reliability studies were conducted using a second observer (FAB, clinical geneticist/pediatrician) who examined 30 patients (9%) of the ASD group, blind to the patients' diagnosis and to the results of morphological assessment of the first examiner. This resulted in a kappa score of 0.81 (Cohen [@CR9]). For the controls, 111 children (11%) were examined by a second observer (RCH) resulting in a kappa score of 0.85. Assessors were blinded to family status and to any previous diagnosis at the time of the assessment.

Data Analysis {#Sec6}
-------------

To better determine whether patients with ASD had higher prevalence of dysmorphology we compared each of the quantitative and qualitative items in carefully selected matched pairs. To reduce the influence of ethnic variability in the matched pairs, analyses were restricted to Caucasian patients and controls. We used procedures in SPSS to match as many patients with autism as possible to controls based on sex and age (±2 years). When more than one control was available for matching to a case, the final match was randomly selected from the pool. Patients with no matching comparison subject were excluded from the analysis.

For the analysis, a binary variable was created for each anomaly such that the presence of an anomaly was scored qualitatively as present "1" or absent "0".

Paired *t*-tests were used to examine differences in morphological features between autistics and controls for continuous variables, McNemar's tests for dichotomous variables and conditional logistic regression for categorical variables. Exact *p* values from the McNemar's test were used to compare controls and patients on these variables. Inflated alpha levels due to multiple testing were addressed by using the Holm-Bonferroni approach to adjust *p*-values. Statistical significance was set at *p* \< .05 (2-tailed) for all analyses (Holm [@CR17]). Matching and data analysis were performed using the Statistical Package for the Social Sciences (SPSS release 15, SPSS Inc., Chicago, IL).

Results {#Sec7}
=======

Demographics {#Sec8}
------------

The development of the sample for the present study is summarized in a flowchart (Supp. Fig. 3)

A total of 442 consecutive patients were invited to participate; of these, 421 agreed to undergo extensive morphological assessments (95.2%). The mean age at examination of the patients was 9.7 years (range 3--18 years), compared with 10.4 years (range 8--14 years) for controls. The male/female ratio was 4.19 in patients and 0.93 in controls. Because of the large age and gender differences between autistics and controls, analyses were performed on matched pairs. There were no significant group differences between case and controls with regard to their socioeconomic background. Supp. Table 1 shows the baseline characteristics for the entire sample and the matched sample. Among 421 cases, 32 subjects were excluded from the analysis as being non-Caucasian, 31 were excluded as not fulfilling ASD criteria. Further, 28 children were excluded from the autistic group due to a diagnosis of a known syndrome or chromosomal abnormality (Supp. Table 2).

After matching on age and gender, 224 patients with autism and 224 controls were available for analysis. Of the 224 matched pairs, 186 (83%) were male, and 38 (17%) were female. The mean (SD) age of patients was 10.6 (2.5) years and the mean age of controls was 10.6 (1.4) years.

Quantitative Measurements {#Sec9}
-------------------------

The matched pairs were compared on height, weight, occipitofrontal circumference (OFC), inner canthal distance (ICD), and outer canthal distance (OCD). The mean differences between the measured anthropometry are given in Table [1](#Tab1){ref-type="table"}. Measurement of BMI, weight, OFC, ICD, and OCD appears to be significantly higher in children with autism than in controls. However, when we stratified the data by gender, differences in BMI and OFC were only statistically significant in male children. Both male and female patients had statistically significant larger ICD and OCD than controls.Table 1Quantitative measurements of the body features (paired sample *t*-test)Boys only (186 pairs, matched by age)Girls only (38 pairs, matched by age)Matched sample (total; matched by sex and age)Mean difference (SE) (control-case)*t*Mean difference (SE) (control-case)*t*Mean difference (SE) (control-case)*t*Height (cm)−1.9 (1.1)−1.7−1.0 (2.4)−0.4−1.7 (1.0)−1.7Weight (kg)−4.9 (1.0)−4.5\*−3.5 (2.6)−1.3−4.7 (1.0)−4.7\*BMI (kg/m^2^)−1.2 (0.2)−4.3\*−1.0 (0.7)−1.3−1.1 (0.2)−4.4\*OFC (cm)\^−0.5 (0.1)−2.9\*−0.2 (0.4)−0.5−0.4 (0.1)−2.9\*ICD (cm)\#−0.1 (0.0)−3.7\*−0.2 (0.0)−2.6\*−0.1 (0.0)−4.3\*OCD (cm)\#−0.8 (0.0)−9.4\*−0.7 (0.1)−4.7\*−0.8 (0.0)−10.3\*PFL (cm)\#−0.3 (0.0)−9.1\*−0.2 (0.0)−3.6\*−0.3 (0.0)−9.7\*Middle finger length (cm)−0.0 (0.0)−1.70.0 (0.1)0.0−0.1 (0.0)−1.6Handpalm length (cm)−0.0 (0.0)−1.00.1 (0.1)0.7−0.0 (0.0)−0.6Hand length (cm)−0.2 (0.1)−1.60.1 (0.2)0.4−0.1 (0.1)−1.3Foot length cm)−0.1 (0.1)−0.40.7 (0.4)1.50.0 (0.1)0.2*OFC* occipito frontal; *BMI* body mass index; *ICD* inner Canthal; *OCD* outer Canthal; *PFL* palpebral fissure\* statistically significant at *p* \< 0.05\# controlling for OFC did not change the results\^ controlling for weight, height, ICD and OCD did not changes the results

Table [1](#Tab1){ref-type="table"} shows the mean quantitative measurements for the total matched sample (*N* = 448 individuals), the female matched (*n* = 76), and the male matched sample (*n* = 372). There was a significant difference in OFC, ICD, and OCD. The mean OFC, ICD, OCD in children with ASD were significantly larger than the mean in controls *p* \< 0.01. ICD and OCD difference remained significant after controlling for OFC. Furthermore, height and weight was calculated as covariates to take the potential effects of general differences in body size into account and to establish the specificity of the OFC effect. Differences in OFC between the autistic and the control group were still significant after controlling for height and weight (*p* \< .05), suggesting that the observed differences in OFC were not due to a generalized enlargement in body size. No differences between autistics and controls were found for height, middle finger length, hand palm length, hand length and foot length.

Occurrence of Morphological Abnormalities in Patients with ASD {#Sec10}
--------------------------------------------------------------

Major abnormalities, minor anomalies and common variants were significantly more prevalent in the patients with ASD, and patients with ASD had a significantly higher occurrence of combinations of major abnormalities, minor anomalies and common variants (Fig. [1](#Fig1){ref-type="fig"}). One or more major abnormalities were present in 43.8% of patients (12.5% in controls, *p* \< .001), two or more abnormalities in 12.1% of patients (0.9% in controls, *p* \< .001), and three or more abnormalities were found in 3.6% compared with none in controls (*p* \< .001; Fig. [1](#Fig1){ref-type="fig"}). One or more minor anomalies were found in 98.2% of patients (58.9% in controls, *p* \< .001), two or more minor anomalies in 89.7% of patients (25.0% in controls, (*p* \< .001), and three or more minor anomalies were found in 77.7% of patients compared with 7.1% in controls (*p* \< .001; Fig. [1](#Fig1){ref-type="fig"}). One or more common variants were found in 100% of patients (89.3% in controls, *p* \< .001), two or more minor anomalies in 98.2% of patients (67.4% in controls, (*p* \< .001), and three or more minor anomalies were found in 95.5% of patients compared with 41.1% in controls (*p* \< .001; Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Prevalence of major abnormalities, minor anomalies and common variants in the matched sample of autistics versus controls

Furthermore, in a univariate analysis, 63 of the 683 morphological features were found to occur significantly (*p* \< .001) more often in patients compared with controls. After correction for multiple testing, 48 morphological abnormalities were significantly (*p* \< .05, two-tailed) more common among patients than controls. The odds ratios (OR's) for the occurrence of these anomalies are shown in Table [2](#Tab2){ref-type="table"}. Thirty-nine of the morphological features were also significantly more common in male matched pairs, and in two of these, the difference was also significantly more frequent in female matched pairs.Table 2Morphological features occurring significantly more frequent in children with autism versus controlsMorphological featureControls (*n* = 224)Autism (*n* = 224)OR (95% CI)*p*Type of abnormality§Brachycephaly018∞ (1.5--∞)0.001Minor anomaly§\#Face asymmetry411327.6 (19.3--73.9)\<0.001Minor anomaly§Face coarse22712.9 (3.2--52.5)\<0.001Minor anomaly§Forehead prominent6538.2 (3.5--19)\<0.001Minor anomaly§Eyes assymetry01513.7 (2--95.1)0.001Minor anomaly§Eyes deeply set9426.4 (2.7--15)\<0.001Minor anomaly§Prominent premaxilla4307.3 (2.6--20.6)0.001Minor anomaly§Mounth asymmetry023∞ (2.3--∞)\<0.001Minor anomalyMacrostomia014∞ (0.9--∞)\<0.001Minor anomalyMicrostomia21514 (1.8--106)0.022Minor anomaly§Short philtrum5356.9 (2.7--17.4)\<0.001Minor anomalyUpper lip cupid bow5255.9 (2.1--16.7)0.032Minor anomaly§\#Palate high/narrow17835.7 (3.2--10)\<0.001Minor anomaly§Long uvula3237.5 (2.3--24.4)Minor anomaly§Macrodontia/teeth asymmetry/abnormally shaped teeth3337.8 (2.8--21.8)\<0.001Minor anomaly§Ear low-set12018.3 (2.7--124)0.004Minor anomaly§Ear posteriorly rotated53310 (3.1--32.2)\<0.001Minor anomalyEar lobe crease012∞ (0.6--∞)0.035Minor anomaly§Toes syndactyly26113.9 (3.4--56.2)\<0.001Minor anomaly§Halluces valgus4299.1 (2.8--29.3)\<0.001Minor anomaly§Hypermobile/hyperlax joints21745.4 (2.9--9.9)\<0.001Minor anomalyMultiple nevi9283.2 (1.5--6.8)0.031Minor anomalyHypo-/depigmentation patches4185.5 (1.6--18.5)0.033Minor anomaly§Face expression less/dull015∞ (1--∞)0.001Major abnormality§Open mouth appearance018∞ (1.5--∞)\<0.001Major abnormality§,^a^Abnormal whorl (non-frontal)087∞ (8.4--∞)\<0.001Common variant§Full cheeks5319.3 (2.9--30)\<0.001Common variant§Periorbital fullness8497.7 (3.3--17.9)\<0.001Common variant§Eyebrows arched13733.7 (5--∞)\<0.001Common variant§Large nose4297 (2.5--19.9)0.002Common variant§Nose bridge prominent28663.5 (1.9--6.2)\<0.001Common variant§Nose concave4276.6 (2.3--18.6)0.006Common variantLower lip full31652.6 (1.6--4,4)0.001Common variant§Upper lip thin21603.4 (1.9--5.9)\<0.001Common variant§Prominent philtrum5305.9 (2.3--15)0.004Common variant§Lower jaw prominent031∞ (0.6--∞)\<0.001Common variant§Dimpled/grooved chin127∞ (0.5--∞)\<0.001Common variant§Prominent ear8405.5 (2.4--12.2)\<0.001Common variant§^,a^Ear lobes attached25784 (2.4--6.9)\<0.001Common variant§Clinodactyly (fingers)11403.6 (1.8--7)0.001Common variant§Clinodactyly (toes)9485.8 (2.7--12.2)\<0.001Common variantInverted nipples6284.6 (1.9--11)0.035Common variantToes widely spaced12220 (2.9--∞)0.001Common variant2nd toe longer than 1st9334.3 (1.9--9.8)0.021Common variant§Pes planus4368.8 (3.1--24.4)\<0.001Common variant§^,a^Sandal gap (toes)571444.4 (2.8--6.8)\<0.001Common variant§Dry skin12606.9 (3.3--14.4)\<0.001Common variant§Nails striped14137.3 (5.6--∞)\<0.001Common variant^a^MPA in Waldrop scale \# Significant in girls (*p* \< 0.05) § Significant in boys (*p* \< 0.05) Forty-eight morphological features occurring significant more frequently in patients with autism compared to controls in univariate analysis (McNemar's test *p* \< 0.05; Holm--Bonferroni corrected)

Discussion {#Sec11}
==========

We have demonstrated a strikingly high prevalence of morphological abnormalities in a large cohort of patients with ASD without mental retardation, compared with controls. The results support existing research findings from a meta-analysis by Ozgen et al. ([@CR32]), as well as those of previous reports in the literature (Steg and Rapoport [@CR39]; Walker [@CR44]; Campbell et al. [@CR7]; Gualtieri et al. [@CR13]; Rodier et al. [@CR34]; Hardan et al. [@CR16]; Miles et al. [@CR28]). In this present study, we tried to overcome the methodological limitations that occurred in previous studies. The main strengths of our study are careful clinical assessments using stringent morphological characterization, robust statistical methods and adequate power relative to previous studies. This sample size of 224 matched patient-control pairs is the largest to be studied to date for morphological features in ASD. Furthermore, in the present study all patients underwent a clinical morphological examination, using a list of 683 well-defined morphological abnormalities, assessed by the same investigator, and co-assessed blindly by a second investigator in about 10%.

Several interesting findings emerged from this study. First, our study demonstrated that the frequency of morphological anomalies is highly elevated in ASD without mental retardation, that not only minor anomalies but also major abnormalities and common variants are significantly more prevalent in children with autism versus controls. Some of the features may be direct malformations whereas others might be indirect e.g., open mouth expression, dry skin, pes planus. This finding resembles that of an association of autism with CNVs, which are common under normal circumstances, but also are an important aspect of genomic disorders, i.e., diseases caused by an alteration of the genome causing complete loss of copy, gain of copy or disruption of a dosage-sensitive gene (Sebat et al. [@CR37]). In fact, Engels et al. ([@CR11]) showed a direct association between the severity of physical anomalies and the gene content of the microdeletions/microduplications.

Second, males with autism showed a trend for more morphological abnormalities scored than females, i.e., males with ASD without mental retardation were notably having significantly more morphological abnormalities than female patients. Although one has to be cautious in interpreting these gender differences because of large differences in sample size, there are many plausible explanations for the observed differences. An explanation might be that the human male brain is generally more vulnerable to endogenous or exogenous factors which are poorly understood (Mizuno [@CR29]). In addition, sex differences in brain structure and development are well known (Baron-Cohen et al. [@CR6]). These results may also substantiate that some genetic risk factors influencing liability to autism in males and females might act differently. Furthermore, in schizophrenia literature there are findings parallel to ours regarding a gender effect on the occurrence of morphological characteristics (McGrath et al. [@CR22]; Akabaliev and Sivkov [@CR3]).

Third, the pattern of changes in morphological features was not straightforward. For example, we found that both smaller and larger mouth size were significantly elevated in patients with ASD compared to controls. Moreover, in contrast to some previous studies (Hardan et al. [@CR16]; Rodier et al. [@CR34]), we did not find that the presently studied patients with ASD had smaller ICD. On the contrary, we found that our patients had larger ICD and OCD, a finding that is consistent with the findings of Walker ([@CR44]) and Bailey et al. ([@CR5]). This observation may suggest either that the direction of changes in the orbital distance may be a random outcome of a common neurodevelopmental defect or that these opposite effects may underlie separate neurodevelopmental defects which might eventually lead to a better characterization of subgroups of patients with autism.

Fourth, in a recent meta-analysis in schizophrenia, a higher prevalence of morphological abnormalities was also established (Weinberg et al. [@CR45]) with similar overlapping markers (e.g., brachycephaly; McGrath et al. [@CR21]). Indeed, there is strong indication that individuals with schizophrenia may display evidence of craniofacial dysmorphology. Some evidence for such an overlap comes from the observation that individuals with ASD may also be at greater risk for schizophrenia (Mouridsen et al. [@CR30]).

There are certain limitations that should be borne in mind when interpreting the results. First, although our sample size provides the necessary statistical power for quantitative analyses, yet some categorical analyses may suffer from power limitations due to the relatively small number of females in the sample. Notably, our sample was predominantly male. The potential difference in morphological features found between males and females require further confirmation.

Second, as morphologic examination requires in-person examination, it is generally not possible for the raters to be blind to diagnosis. However, 11% of controls and 9% of patients were scored independently by two observers, resulting in high kappa scores. Additionally there were no prior hypotheses as of which morphological abnormalities should be associated with autism.

Third, we limited our study population to Caucasian patients and controls as ethnicity can influence the prevalence of morphological abnormalities. Future studies are needed to establish similar norms for other ethnic groups. Likewise, we restricted ourselves to non-mentally retarded ASD patients. Therefore, we cannot generalize our findings to mentally retarded ASD patients or patient subgroups.

Forth, it is typically quite a challenge to determine whether these features are risk factors. The possible causal relevance of the association between disturbed prenatal development and subsequent autism has stimulated considerable discussion. In the present consideration of causality, we do not suggest that abnormal morphology in itself causes autism. In addition, we acknowledge that there are many disorders with similar morphological characteristics. e.g., increased head size. The same feature has already been shown to be related to a particular SNP variant in people with autism (Conciatori et al. [@CR10]) as well as in people without a diagnosis (Muscarella et al. [@CR31]). On the other hand, people with a very different etiology for autism, in utero exposure to valproic acid, also exhibit increased head size (Rasalam et al. [@CR33]). Further studies are needed to discover the specificity, sensitivity and predictive value of these features for ASD. Moreover, some of the morphological characteristics among families may not be related to the ASD; demonstrating a genetic component independent of any syndrome and condition. Therefore, we recommend sib comparisons as future studies.

Last, the goal of this analysis was to provide a detailed analysis for the association of morphological features and ASD without mental retardation. We have not been able to address other intriguing questions such as clustering of the morphological features in different subgroups of ASD. These associations probably exist but are beyond the scope of this study. While we did not intend to establish specificity of single phenotypic characteristics to specific subtypes of ASD, we consider it possible that sets of physical anomalies might be related to severity of illness, or those specific phenotypic behavioral characteristics may define even more subtypes of ASD.

The current findings may have implications for future research, psychiatric nosology and clinical practice. With regard to future research implications, our findings help to reconcile previous puzzling evidence about the relationship between morphological features and ASD such as the inconsistency of this association across topographical areas. With regard to psychiatric nosology, our study adds to a growing body of research that suggests that morphological features might identify subgroups of individuals with ASD. It is possible that a subgroup of individuals with a higher number of unusual morphological findings or specific combinations of morphological findings is at highest risk of developing ASD without mental retardation. With regard to implications for clinical practice, our results support the importance of measuring morphological features in individuals with ASD. We suggest that routine assessment of quantitative and qualitative measurements could provide clinicians with necessary information to homogenise the ASD. In turn, the early recognition of the risk associated with morphological abnormalities might help to address pressing needs for the care of individuals with ASD.
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